|
|
| (Eine dazwischenliegende Version von einem Benutzer wird nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| − | {{tp|p=31560483|t=2019. Oxigenoterapia con canula nasal de alto flujo en lactantes con infeccion respiratoria baja aguda. Experiencia en hospitales de la Ciudad de Buenos Aires.|pdf=|usr=018}}
| + | |
| − | {{tp|p=32671470|t=2020. Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure.|pdf=|usr=014}}
| + | *[https://gab.com/TomDoniphon/posts/104162938810676022 proposal of iron lungs (kinderlähmung times)] |
| − | {{tp|p=32737522|t=2020. Monitoring of high-flow nasal cannula for SARS-CoV-2 severe pneumonia: less is more, better look at respiratory rate.|pdf=|usr=018}}
| + | |
| − | {{tp|p=32758000|t=2020. High Flow Nasal Canula in Critically Ill Severe COVID-19 Patients.|pdf=|usr=018}}
| + | |
| − | {{tp|p=32753062|t=2020. Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure.|pdf=|usr=017}}
| + | |
| − | {{tp|p=32826432|t=2020. High-Flow Nasal Oxygen in Coronavirus Disease 2019 Patients With Acute Hypoxemic Respiratory Failure: A Multicenter, Retrospective Cohort Study.|pdf=|usr=018}}
| + | |
| − | {{tp|p=32847947|t=2020. Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.|pdf=|usr=018}}
| + | |
| − | {{tp|p=32880537|t=2020. The utility of high-flow nasal cannula oxygen therapy in the management of respiratory failure secondary to COVID-19 pneumonia.|pdf=|usr=018}}
| + | |
| − | {{tp|p=C7283709|t=?. Reducing aerosol dispersion by High Flow Therapy in COVID?19: High Resolution Computational Fluid Dynamics Simulations of Particle Behavior during High Velocity Nasal Insufflation with a Simple Surgical Mask.|pdf=|usr=015}}
| + | |
